Evidence map›Paper›PMID 28662116›Full record

ArticlePloS one2017

Actinic keratosis modelling in mice: A translational study.

Arnaud Pillon, Bruno Gomes, Isabelle Vandenberghe, Valérie Cartron, Patrick Cèbe, Jean-Christophe Blanchet, Vincent Sibaud, Nicolas Guilbaud, Laurent Audoly, Laurence Lamant and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Prevention of supercritical carbon dioxide fluid extract fromExperimental and therapeutic medicine · 2024
    Article
  4. Article
  5. Topical GZ21T Inhibits the Growth of Actinic Keratoses in a UVB-Induced Model of Skin Carcinogenesis.JID innovations : skin science from molecules to population health · 2023
    Article
  6. Construction of a Secondary Enclosure for UVB Irradiation of Mice.JID innovations : skin science from molecules to population health · 2023
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Arnaud PillonPierre Fabre Research Institute, Research & Development Center, Toulouse, France.ORCID http://orcid.org/0000-0002-7057-5980
Bruno GomesPierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Isabelle VandenberghePierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Valérie CartronPierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Patrick CèbePierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Jean-Christophe BlanchetPierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Vincent SibaudDepartment of Dermatology, University Cancer Institute of Toulouse, Toulouse, France.
Nicolas GuilbaudPierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Laurent AudolyPierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Laurence LamantDepartment of Pathology, University Cancer Institute of Toulouse, Toulouse, France.
Anna KruczynskiPierre Fabre Research Institute, Research & Development Center, Toulouse, France.
Pierre Fabre (France) · FRInstitut universitaire du cancer de Toulouse Oncopole · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActinic keratoses (AK) are pre-malignant cutaneous lesions caused by prolonged exposure to ultraviolet radiation. As AKs lesions are generally accepted to be the initial lesions in a disease continuum that progresses to squamous cell carcinoma (SCC), AK lesions have to be treated. They are also the second most common reason for visits to the dermatologist. Several treatments are available but their efficacy still needs to be improved. The UV-B-induced KA lesion mouse model is used in preclinical studies to assess the efficacy of novel molecules, even though it is often more representative of advanced AK or SCC.

objectivesHere we report on a translational study, comparing the various stages of AK development in humans and in the UV-B irradiated mouse model, as well as the optimization of photograph acquisition of AK lesions on mouse skin.

methodsHuman and mouse skin lesions were analysed by histology and immunohistochemistry. Mouse lesions were also assessed using a digital dermatoscope.

resultsAn histological and phenotypic analysis, including p53, Ki67 and CD3 expression detection, performed on human and mouse AK lesions, shows that overall AK modelling in mice is relevant in the clinical situation. Some differences are observed, such as disorganization of keratinocytes of the basal layer and a number of atypical nuclei which are more numerous in human AK, whereas much more pronounced acanthosis is observed in skin lesion in mice. Thanks to this translational study, we are able to select appropriate experimental conditions for establishing either early or advanced stage AK or an SCC model. Furthermore, we optimized photograph acquisition of AK lesions on mouse skin by using a digital dermatoscope which is also used in clinics and allows reproducible photograph acquisition for further reliable assessment of mouse lesions. Use of this camera is illustrated through a pharmacological study assessing the activity of CARAC®.

conclusionThese data demonstrate that this mouse model of UV-B-induced skin lesions is predictive for the identification of novel therapeutic treatments for both early and advanced stages of the disease.

Indexed as

Disease Models, AnimalTranslational Research, BiomedicalAnimalsDermoscopyFluorouracilHumansImmunosuppressive AgentsKeratosis, ActinicMiceMice, HairlessUltraviolet RaysFluorouracilImmunosuppressive Agents

Identifiers

PMID28662116
PMCPMC5491107
OpenAlexW2732550912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.